Lipase, Body Fluid
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Investigating pancreatic disorders, usually pancreatitis or pancreatic pseudocysts
Colorimetric Rate Reaction
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Container/Tube: Sterile container
Specimen Volume: 1 mL
Collection Instructions: Centrifuge to remove any cellular material.
Additional Information: Indicate specimen source.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Mild OK; Gross reject
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
|Body Fluid||Frozen (preferred)||90 days|
Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Lipases are enzymes that hydrolyze glycerol esters of long-chain fatty acids and produce fatty acids and 1-acylglycerol. Bile salts and a cofactor, colipase, are required for full catalytic activity and greatest specificity. The pancreas is the primary source of serum lipase. Both lipase and colipase are synthesized in the pancreatic acinar cells and secreted by the pancreas in roughly equimolar amounts. Serum lipase is filtered and reabsorbed by the kidneys. Pancreatic injury results in increased serum lipase levels.
In pancreatitis, serum lipase becomes elevated at about the same time as serum amylase (in 4-8 hours). But serum lipase may rise to a greater extent and remain elevated much longer (7-10 days) than serum amylase. Elevations in serum lipase up to 50 times the upper reference values have been reported. The increase in serum lipase is not necessarily proportional to the severity of the attack and normalization is not necessarily a sign of resolution.
Both lipase and amylase should be very elevated in peritoneal fluid arising from the pancreas. Values in fluid of pancreatic origin should be at least several-fold higher than serum drawn at the same time, even in acute pancreatitis.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Very high values are consistent with pancreatic pseudocysts.
Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
Collection tubes with glycerol-lubricated stoppers or tubes containing citrate, oxalate, or EDTA should not be used.
Method Description Describes how the test is performed and provides a method-specific reference
The instrument used is a Roche P Modular. The lipase method is an enzymatic colorimetric method in which lipase catalyzes the hydrolysis of a natural 1,2-diglyceride to form monoglyceride and fatty acid. Monoglyceride is hydrolyzed by monoglyceride lipase to form glycerol and fatty acid. Glycerol is then phosphorylated by glycerol kinase in the presence of ATP to form glycerol-3-phosphate, which is oxidized by glyderol-3-phosphate oxidase to form dihydroxyacetone phosphate and hydrogen peroxide. Subsequently, hydrogen peroxide reacts with 4-aminoamtipyrine and sodium N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine in the presence of peroxidase to form quinine diimine dye. The dye absorbs light at 550 nm. The rate of increase in absorbance at 550 nm is directly proportional to the pancreatic lipase activity in the specimen. The method is sensitive and specific for pancreatic lipase and utilizes co-lipase and deoxycholate as activators. (Package insert: Equal Diagnostics Lipase reagent, Exton PA)
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Sunday; Continuously
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Same day/1 day
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location The location of the laboratory that performs the test
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test has been modified from the manufacturer’s instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|